Mechanism of SEMA3B gene silencing and clinical significance in glioma.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Genetics and Molecular Research

• Publication date

  2016-03-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.4238/gmr.15017664PMID 27050958
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• All-trans retinoic acid upregulates VEGF expression in glioma cells in vitro

  2012cited by this paper
• Rad51 and BRCA2 - New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer Drugs

  2011cited by this paper
• Autocrine Netrin Function Inhibits Glioma Cell Motility and Promotes Focal Adhesion Formation

  2011cited by this paper
• Stereotactic brachytherapy of low-grade cerebral glioma after tumor resection.

  2011cited by this paper
• Serum vascular endothelial growth factors C and D in patients with oesophageal cancer.

  2010cited by this paper
• Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?

  2008cited by this paper
• High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.

  2007cited by this paper
• Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001.

  2006cited by this paper
• Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer

  2001cited by this paper
• The Role of the Hemostatic System in Tumor Growth, Metastasis, and Angiogenesis: Tissue factor is a Bifunctional Molecule Capable of Inducing Both Fibrin Deposition and Angiogenesis in Cancer

  2001cited by this paper
• Expression of osteopontin in human glioma. Its correlation with the malignancy.

  1995cited by this paper
• Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients.

  1993cited by this paper

• Advances in semaphorin 3B research in tumors (Review)

  2026cites this paper
• SEMA3B‐AS1 suppresses colorectal carcinoma progression by inhibiting Semaphorin 3B‐dependent VEGF signaling pathway activation

  2023cites this paper
• Emerging roles and mechanisms of semaphorins activity in cancer.

  2023cites this paper
• High STK40 Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Low-Grade Gliomas

  2021cites this paper
• Cisplatin changes expression of SEMA3B in endometrial cancer.

  2020cites this paper
• Regulatory effects of Lactobacillus plantarum HY7714 on skin health by improving intestinal condition

  2020cites this paper
• MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression

  2019cites this paper
• Epidermal growth factor‐containing fibulin‐like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B)

  2019cites this paper
• Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma

  2019cites this paper
• Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression

  2019cites this paper